You may report side effects to FDA at 1-800-FDA-1088. Delays in diagnosis and institution of therapy may have deleterious effects on the child's intellectual and physical growth and development. Nursing Mothers Although thyroid hormones are excreted only minimally in human milk, caution should be exercised when Synthroid is administered to a nursing woman. Different brands of levothyroxine may not work the same. Package Label.Principal Display Panel NDC 0074–6624–71 Synthroid® (levothyroxine Sodium Tablets, USP) www.Synthroid.com This package for households without young children Rx Only synthroid and breast cancer Label.Principal Display Panel NDC 0074–6624–11 100 Tab Abbo-Pac® Abbo-Pac Unit Dose Synthroid® (levothyroxine Sodium Tablets, USP) 100 mcg synthroid and breast cancer mg) Rx Only Tamper Evident: Do not accept if seal over bottle opening is broken or missing.
synthroid tablet colors
40 Product Characteristics Color PINK Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;200 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-7148-13 100 TABLET In 1 BOTTLE None 2 0074-7148-19 1000 TABLET In 1 BOTTLE None 3 0074-7148-71 28 TABLET In 1 BOX None 4 0074-7148-11 10 BLISTER PACK In 1 BOX, UNIT-DOSE contains a BLISTER PACK 4 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-7148-11) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 02/24/2002 Labeler - Abbott Laboratories (001307602) Revised: 05/2009Abbott Laboratories Synthroid Generic name: Levothyroxine Brand names: Synthroid, Levothroid, Levoxyl, Unithroid Why is Synthroid prescribed? Synthroid, a synthetic thyroid hormone may be given in any of the following cases: If your own thyroid gland is not making enough hormone; If you have an enlarged thyroid (a goiter) or are at risk for developing a goiter; If you have certain cancers of the thyroid; If your thyroid production is low due to surgery, radiation, certain drugs, or synthroid and breast cancer of the pituitary gland or hypothalamus in the brain. 6 Aluminum Lake, FD&C Blue No. In addition, many drugs and foods affect T4 absorption (see PRECAUTIONS - Drug Interactions and Drug-Food Interactions ). Overtreatment with levothyroxine sodium may have adverse cardiovascular effects such as an increase in heart rate, cardiac wall thickness, and cardiac contractility and may precipitate angina or arrhythmias. Generally, replacement therapy is to be taken for life, except in synthroid and breast cancer of transient hypothyroidism, which is usually associated with an inflammation of the synthroid and breast cancer gland (thyroiditis). Although there has been a reported association between prolonged thyroid hormone therapy and breast cancer, this has not been confirmed. These include urticaria, pruritus, skin rash, flushing, angioedema, various GI symptoms (abdominal pain, nausea, vomiting and diarrhea), fever, arthralgia, serum sickness and wheezing. 1 Aluminum Lake 150 FD&C Blue No. Digitalis glycosides The therapeutic effects of digitalis glycosides may be reduced by levothyroxine. Ask your doctor before you change the dose of your diabetes medicine. The following information includes only the average doses of this medicine. It may take several weeks before your body starts to respond to this medication. 1 Product Characteristics Color GREEN Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;300 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-7149-13 100 TABLET In 1 BOTTLE None 2 0074-7149-19 1000 TABLET In 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-4341 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 25 ug Inactive Ingredients synthroid and breast cancer Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C YELLOW NO. Undertreatment may result in synthroid and breast cancer school performance due to impaired concentration and slowed mentation and in reduced adult height. Notify your physician of any other medical conditions you may have, particularly heart disease, diabetes, clotting disorders, and adrenal or pituitary gland problems. Thyroid hormones do not readily cross the placental barrier (see PRECAUTIONS - Pregnancy). Tell your doctor about all synthroid and breast cancer you use. It is important to take Synthroid exactly as prescribed. The recommended frequency of monitoring of TSH and total or free T4 in children is as follows: at 2 and 4 weeks after the initiation of treatment; every 1-2 months during the first year synthroid and breast cancer life; every 2-3 months between 1 and 3 years of age; and every 3 to 12 months thereafter until growth is completed. Call your doctor for medical advice about side effects.
Maternal hypothyroidism may have an adverse effect on fetal and childhood growth and development. synthroid and breast cancer you suspect a massive overdose, seek emergency medical attention immediately. Do not take extra medicine to make up the missed dose. Failure to do so may precipitate an acute adrenal crisis when thyroid hormone therapy is initiated, due to increased metabolic clearance of glucocorticoids by thyroid hormone. For patients who have recently initiated levothyroxine therapy and whose serum TSH has normalized or in patients who have had their dosage or brand synthroid and breast cancer levothyroxine changed, the serum TSH concentration should be measured after 8-12 weeks. The recommended frequency of monitoring of TSH and total or free T4 in children is as follows: at 2 and 4 weeks after the initiation of treatment; every 1-2 months during the first year of life; every 2-3 months between 1 and 3 years of age; and every 3 to 12 months thereafter until growth is completed. 1 Product Characteristics Color GREEN Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;300 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-7149-13 100 TABLET In 1 BOTTLE None 2 0074-7149-19 1000 TABLET In 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-4341 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 25 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C YELLOW NO. Adults In adult patients with primary (thyroidal) hypothyroidism, serum TSH synthroid and breast cancer (using a sensitive assay) alone may be used to monitor therapy. Levothyroxine is contraindicated in patients with uncorrected adrenal insufficiency since thyroid hormones may precipitate an acute adrenal crisis by increasing the metabolic clearance of glucocorticoids (see PRECAUTIONS). In addition, thyroid hormones and thyroid status have varied effects on the pharmacokinetics and actions synthroid and breast cancer other drugs. 6 Aluminum Lake 112 D&C Red No.